A quality by design study applied to an industrial pharmaceutical fluid bed granulation

被引:81
作者
Lourenco, Vera [1 ,2 ]
Lochmann, Dirk [1 ]
Reich, Gabriele [3 ]
Menezes, Jose C. [2 ]
Herdling, Thorsten [1 ]
Schewitz, Jens [1 ]
机构
[1] Merck KGaA, PAT Lab, Qual Operat, D-64293 Darmstadt, Germany
[2] Univ Tecn Lisboa, IST, Inst Biotechnol & Bioengn, Lisbon, Portugal
[3] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany
关键词
Quality by Design; Process Analytical Technology; Design Space; Multivariate data analysis; Fluid bed granulation;
D O I
10.1016/j.ejpb.2012.03.003
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The pharmaceutical industry is encouraged within Quality by Design (QbD) to apply science-based manufacturing principles to assure quality not only of new but also of existing processes. This paper presents how QbD principles can be applied to an existing industrial pharmaceutical fluid bed granulation (FBG) process. A three-step approach is presented as follows: (1) implementation of Process Analytical Technology (PAT) monitoring tools at the industrial scale process, combined with multivariate data analysis (MVDA) of process and PAT data to increase the process knowledge; (2) execution of scaled-down designed experiments at a pilot scale, with adequate PAT monitoring tools, to investigate the process response to intended changes in Critical Process Parameters (CPPs); and finally (3) the definition of a process Design Space (DS) linking CPPs to Critical to Quality Attributes (CQAs), within which product quality is ensured by design, and after scale-up enabling its use at the industrial process scale. The proposed approach was developed for an existing industrial process. Through enhanced process knowledge established a significant reduction in product CQAs, variability already within quality specifications ranges was achieved by a better choice of CPPs values. The results of such step-wise development and implementation are described. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:438 / 447
页数:10
相关论文
共 20 条
[1]
[Anonymous], 2004, Food and Drug Administration Guidance for industry PATa framework for innovative pharmaceutical development, manufacturing and quality Assurance
[2]
[3]
Brereton R.G., 2003, DATA ANAL LAB CHEM P
[4]
DOSCHER C, 1994, ZUCKERINDUSTRIE, V119, P375
[5]
EDQM, 2008, EUR PHARM, V1, P261
[6]
ERIKSON L, 2006, MULTI MEGAVARIATE 1
[7]
FDA, 2002, GUID PHARM CGMPS 21
[8]
Food and Drug Administration (FDA), 2011, Guidance for Industry, Process Validation: General Principles and Practices
[9]
ICH, 2009, GUID Q8R2 PHARM DEV
[10]
IEC, IEC 60812: Analysis Techniques for System Reliability-Procedure for Failure Mode and Effects Analysis (FMEA)